NMC allows FMGs to undergo mandatory internship at non-teaching hospitals for two more years

In a major relief to the Foreign Medical Graduates (FMGs), the National Medical Commission (NMC) has allowed them to undergo the mandatory internship at non-teaching hospitals for two more years. The NMC relief comes on the basis of various representations received from Medical Councils and FMGs about facing difficulties in the deployment of FMGs for internship.

Last year, the Apex Medical Commission granted this relief to the FMGs after taking note of the inadequate number of available internship seats, due to which several medical graduates from abroad could not get enrolled in the internship programme despite clearing the Foreign Medical Graduates Examination (FMGE), the mandatory screening test.

For more information click on the link below:

NMC Relief: FMG Internship Allowed At Non-Teaching Hospitals For 2 More Years

Powered by WPeMatico

Kerala doctor suspended for conducting surgery on tongue instead of finger

In a shocking incident, a Government doctor in Kerala, working in the post of Associate Professor, has recently been suspended by the State Government for allegedly conducting surgery on a four-year-old girl’s tongue instead of her finger.
According to PTI report, the little girl was taken to the operating theatre at the Government Medical College Hospital on Thursday for the removal of her sixth finger. However, hours later, when she emerged from the surgery, it was discovered that the operation was performed on her tongue ‘mistakenly’.
For more information, click on the link below:

Powered by WPeMatico

Health Bulletin 18/ May/ 2024

Here are the top health stories for the day:

NMC relief: FMG internship allowed at Non-Teaching hospitals for 2 more years

In a major relief to the Foreign Medical Graduates (FMGs), the National Medical Commission (NMC) has allowed them to undergo the mandatory internship at non-teaching hospitals for two more years. The NMC relief comes on the basis of various representations received from Medical Councils and FMGs about facing difficulties in the deployment of FMGs for internship.

Last year, the Apex Medical Commission granted this relief to the FMGs after taking note of the inadequate number of available internship seats, due to which several medical graduates from abroad could not get enrolled in the internship programme despite clearing the Foreign Medical Graduates Examination (FMGE), the mandatory screening test.

For more information click on the link below:

NMC Relief: FMG Internship Allowed At Non-Teaching Hospitals For 2 More Years

NEET-UG 2024: Supreme Court refuses to stay declaration of NEET results over alleged paper leak

The paper leak scandal involving the National Eligibility-cum-Entrance Test Undergraduate (NEET-UG) 2024 Exam has now reached the Supreme Court. While the bench refused to grant a stay on the exam results, it has agreed to consider the matter and issue notice on the Public Interest Litigation seeking re-conduction of the NEET UG exams in light of the alleged malpractices and paper leak scam.

The bench comprising Chief Justice of India DY Chandrachud and Justices JB Pardiwala and Manoj Misra has posted the matter for further hearing after the summer vacations (in July). However, the CJI observed that the results of ‘an all-India exam’ cannot be stayed at the moment, Live Law has reported.

For more information, click on the link below:

NEET 2024 Paper Leak Matter Reaches Supreme Court, Plea Seeking Stay On Results Declaration Junked


AP doctor performs CPR on child who collapsed after electric shock, saves life in viral video

In a heartwarming display of medical heroism, an Andhra Pradesh doctor’s quick actions saved the life of a 6-year-old boy who was electrocuted in Ayyappa Nagar, Vijayawada. The boy’s frantic parents were carrying him along the road when he suddenly went into cardiac arrest.

Dr. Ravalika, who happened to be passing by, noticed the distress and immediately sprang into action. Demonstrating remarkable presence of mind, she performed CPR (Cardiopulmonary Resuscitation) on the boy right there on the road. A video captured the tense moments as Dr.Ravalika continuously thumped the boy’s chest while he lay lifeless, with passersby clearing the road to allow her space to work.

Teen died of cardiac arrest after eating spicy tortilla chip packaged in coffin-shaped box: Autopsy

A 14-year-old boy from Massachusetts, Harris Wolobah, tragically died of cardiac arrest last year after participating in the “One Chip Challenge,” a social media dare involving consuming an extremely hot tortilla chip. The challenge, popularized by the chip company Paqui, features a single chip dusted with Carolina Reaper and Naga Viper peppers. The autopsy report, released Thursday, revealed that Harris’s death was caused by cardiac arrest induced by capsaicin, a compound found in chili peppers, and noted that he had an enlarged heart, which may have contributed to his death.

Following Harris’s death in September, Paqui removed the product from store shelves. The chip was sold in a coffin-shaped box with a red skull and marked ‘extreme heat.’

Powered by WPeMatico

SJN Homoeopathic Medical College faculty suspended over complaints of harassment by female students

Guwahati: Taking action against a doctor over allegations of physical harassment by two female students at SJN Homoeopathic Medical College & Hospital in Guwahati’s Panjabari, the Directorate of Medical Education, Assam suspended him on grounds of gross misconduct.

The action was taken after the two female students of the medical college filed a complaint of harassment against the doctor who serves as a Reader in the Department of Organon Medicine at the hospital. 

Taking note of the serious allegations, a show cause notice was served to the doctor before his suspension order seeking an explanation for his actions. However, he failed to provide any specific reason justifying his behaviour. 

Also read- Kerala Shocker: Doctor Performs Surgery On Tongue Instead Of Finger! Suspended

In response to his failed attempt to prove the allegations wrong, the medical education department took action against him by suspending him with immediate effect and cited the reason as “gross misconduct”.

An order issued by the medical education department in this regard stated, “Therefore, in view of the aforementioned gross misconduct committed by Dr. Tirtha Dyuti Choudhury, Reader, Department of Organon of Medicine, SJN Homeopathic Medical College & Hospital, is placed under suspension with immediate effect pending drawal of Disciplinary Proceedings”.

“During the period of suspension, Dr Tirtha Dyuti Choudhury, Reader, Department of Organon of Medicine, SJN Homeopathic Medical College & Hospital will be paid subsistence allowance as per rule, and he is barred from carrying out private practice or any other employment, business, profession or vocation as stipulated in F.R.53(2), until further orders,” as reported by Pratidin time

Even with the chance to offer a defence, Dr Choudhury failed to provide any compelling rationale for his actions.

As per a media report in India Today NE, In response to the gravity of the situation and the lack of a satisfactory explanation from Dr Choudhury, the Medical education department took swift action by suspending him from his duties with immediate effect.

Also read- Fake Organ Transplant NOC Case: SMS Hospital Surgeon Suspended

Powered by WPeMatico

Medical Bulletin 18/ May/ 2024

Here are the top medical news for the day:

Early death caused by metabolism-related risk factors has increased by 50%, study finds
The latest findings from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD), recently published in The Lancet, offered insights into health challenges and the risk factors contributing to metabolism-related death.
An increase in people experiencing metabolic risk factors, such as high systolic blood pressure (SBP), high fasting plasma glucose (FPG), high body mass index (BMI), high LDL cholesterol, and kidney dysfunction, demonstrates the consequences of an aging population and changing lifestyles on a global scale.
Metabolic risk factors lead to significant health problems by disrupting the body’s normal physiological functions. These factors strain the cardiovascular system, impair kidney function, and disrupt glucose metabolism, resulting in overall decreased organ efficiency. Over time, this chronic strain can cause systemic inflammation, reduced immune response, and impaired healing processes, leaving individuals more susceptible to infections, chronic fatigue, reduced quality of life and increased mortality risk.
According to the study, there was a 49.4% increase in the number of global disability-adjusted life years (lost years of healthy life due to poor health and early death), attributable to metabolism-related risk factors between 2000 and 2021. Over this period, ill health in people ages 15–49 was increasingly attributable to a high BMI and high FPG – also known as high blood sugar – which increases the risk of developing diabetes. Other metabolic risk factors were also in the top 10 risk factors for people in this age group.
“Though metabolic in nature, developing these risk factors can often be influenced by various lifestyle factors, especially among younger generations. They also are indicative of an aging population that is more likely to develop these conditions with time. Targeting the reduction of preventable, non-communicable diseases through modifiable risk factors presents an enormous opportunity to pre-emptively alter the trajectory of global health through policy and education,” said Dr. Michael Brauer, Affiliate Professor at the Institute for Health Metrics and Evaluation (IHME).
“Risk factors that currently lead to ill health, such as obesity and other components of metabolic syndrome, exposure to ambient particulate matter air pollution, and tobacco use, must be addressed via a combination of global health policy efforts and exposure reduction to mitigate health risks and improve population health. With increasing exposure to risk factors such as high blood sugar, high blood pressure, low physical activity, and diet high in sugar-sweetened beverages—there is an urgent need for interventions focused on obesity and metabolic syndromes,” said the authors.
Reference: GBD 2021 Risk Factors Collaborators- Michael Brauer*, Gregory A Roth*, Aleksandr Y Aravkin, Peng Zheng, et al.; Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021; The Lancet; DOI:https://doi.org/10.1016/S0140-6736(24)00933-4
Study sheds light on benefits of exercise on brain health
New research published in the journal Aging Cell provided insights into how exercise may help to prevent or slow cognitive decline during ageing.
Ageing induces progressive physiological changes to multiple body systems over time. In humans, ageing is associated with a decline in both general physical well-being and cognitive abilities.
Observational studies in aged individuals consistently suggest that exercise can alleviate age-related deficits in multiple physiological systems, including the brain.
Exercise can reverse grey matter loss in the hippocampus, an area important for learning and memory. While the mechanisms underlying these benefits remain poorly defined, exercise in general is known to increase neurotrophin expression, enhance synaptic plasticity and modulate the expression of various immune factors in the aged brain. It also modulates the heightened ageing-associated response of microglia to immune challenge.
For the study, investigators assessed the expression of genes in individual cells in the brains of mice. The team found that exercise has a significant impact on gene expression in microglia, the immune cells of the central nervous system that support brain function. Specifically, the group found that exercise reverts the gene expression patterns of aged microglia to patterns seen in young microglia.
Treatments that depleted microglia revealed that these cells are required for the stimulatory effects of exercise on the formation of new neurons in the brain’s hippocampus, a region involved in memory, learning, and emotion.
The scientists also found that allowing mice access to a running wheel prevented and reduced the presence of T cells in the hippocampus during aging. These immune cells are not typically found in the brain during youth, but they increase with age.
“We were both surprised and excited about the extent to which physical activity rejuvenates and transforms the composition of immune cells within the brain, in particular the way in which it was able to reverse the negative impacts of aging. It highlights the importance of normalizing and facilitating access to tailored exercise programs. Our findings should help different industries to design interventions for elderly individuals who are looking to maintain or improve both their physical and mental capabilities,” said co–corresponding author Jana Vukovic of The University of Queensland, in Australia.
Reference: Solal Chauquet, Emily F. Willis, Laura Grice, Samuel B. R. Harley, Joseph E. Powell, Naomi R. Wray, Quan Nguyen, Marc J. Ruitenberg, Sonia Shah, Jana Vukovic; Exercise rejuvenates microglia and reverses T cell accumulation in the aged female mouse brain; Aging Cell; https://doi.org/10.1111/acel.14172
ICMR dietary guidelines 2024 highlight Palm Oil as a better dietary choice
The Indian Council of Medical Research (ICMR) and the National Institute of Nutrition (NIN) have recently released the “Dietary Guidelines for Indians-2024,” highlighting the nutritional significance of using a diverse variety of oil seeds, nuts and whole grains for providing a balance of all fatty acids (lipids).
The guidelines underscored the essential role of dietary fats in nutrition. Fats provide concentrated energy, aid in the absorption of nutrients, and enhance the overall satisfaction of a diet. Among the oils recognised for their health benefits, palm oil was highlighted due to its balanced composition of fatty acids and a rich nutrient profile. It is included alongside other beneficial oils such as groundnut, cottonseed, sesame, and olive, which are all noted for their high content of monounsaturated fatty acids.
Palm oil, in particular, helps lower blood cholesterol levels and these benefits are attributed to the oil’s minor components like tocopherols and sterols, which are largely antioxidants. While palm oil and other plant-based oils are rich in monounsaturated fatty acids, they also contain polyunsaturated fatty acids such as linoleic (n-6) and linolenic (n-3) acids, found only in plant foods.
“Like all vegetable oils, palm oil does not contain cholesterol, which is found only in animal-based foods. Instead, plant oils include beneficial substances such as lignans, sterols, tocopherols (vitamin E), oryzanol, and carotenoids, which are known to reduce cholesterol and oxidative damage associated with ageing and chronic diseases,” stated the guidelines.
“The unique balance of saturated, monounsaturated, and polyunsaturated fatty acids in palm oil makes it a valuable addition to a healthy diet. The guidelines note that the low concentration of polyunsaturated fats in palm oil reduces its pro-inflammatory properties, and its balanced fatty acid composition can help maintain healthy cholesterol levels by increasing high-density lipoprotein (HDL) cholesterol and reducing low-density lipoprotein (LDL) cholesterol.”
The comprehensive report emphasized the importance of a balanced intake of fats, recommending moderation and a variety of food sources to ensure a well-rounded nutritional profile. By making informed choices and integrating diverse food sources, individuals can enhance their well-being and reduce the risk of chronic diseases.
Reference: DIETARY GUIDELINES FOR INDIANS, ICMR- National Institute of Nutrition

Powered by WPeMatico

Boehringer Ingelheim Spevigo injection for generalized pustular psoriasis flares gets CDSCO nod

Mumbai: The Central Drugs Standard Control Organisation (CSDCO) in India has approved Boehringer Ingelheim’s SPEVIGO (spesolimab) injection, a first-in-class treatment for generalised pustular psoriasis (GPP) flares in adults.

Spesolimab is a novel, selective antibody that blocks the activation of the interleukin-36 receptor (IL-36R), a signaling pathway within the immune system shown to be involved in the pathogenesis of GPP. 

In the EFFISAYIL 1 Phase II global clinical trial, patients experiencing a GPP flare were treated with spesolimab or placebo. Most patients at the outset of the trial had a high, or very high, density of pustules, and impaired quality of life. After one week, 54% of patients treated with spesolimab showed no visible pustules compared to placebo (6%).

In India, GPP presents a significant healthcare challenge, affecting individuals of all ages and demographics. While precise prevalence data for GPP in India is limited, GPP is widely recognized as a rare disease.

GPP is a rare and unpredictable systemic disease, with predominant skin symptoms, that is distinct from plaque psoriasis in both its disease mechanism and severity. Given that it is so rare, recognizing the symptoms can be challenging, which lead to delays in diagnosis. It manifests with painful pus-filled blisters, redness, inflammation, and scaling on the skin, often accompanied by systemic symptoms like fever and fatigue. Timely diagnosis and treatment are crucial, yet challenges in misdiagnosis and delayed intervention persist, due to the rarity of GPP and its similarities to other skin conditions like psoriasis, leading to inadequate management and prolonged suffering for patients. Moreover, triggers for GPP flares, including stress, infections, certain medications, hormonal changes, and environmental factors, vary widely among individuals, making it challenging to predict and manage the condition effectively.

“The approval of SPEVIGO by the CDSCO represents a significant milestone in GPP management in India and underscores our commitment to bring novel therapies into the country. We often take our skin for granted. However, for a small percentage of people with a rare, lifelong skin disorder, living in constant anticipation of possible flares that could require emergency medical care is a harsh reality. Some patients often describe the feeling akin to ‘being on fire’. SPEVIGO’s impact goes beyond treatment; it’s about giving patients the chance to reclaim their lives. It presents a promising opportunity for enhancing effective management, quality of life, and patient outcomes in India, instilling hope for individuals grappling with GPP,” said Gagandeep Singh Bedi, Managing Director, Boehringer Ingelheim India.

Dr. Shraddha Bhure, Medical Director, Boehringer Ingelheim India highlighted the significance of this development. “GPP is a debilitating condition, with serious symptoms like flares and pustules that can significantly impact patients’ ability to perform daily activities, often leading to significant morbidity and impaired quality of life. SPEVIGO, a targeted therapy, has been shown to effectively reduce the severity of GPP flares, providing patients with an innovative treatment that specifically targets the underlying inflammation associated with GPP, thus providing relief from the distressing symptoms of the disease.”

People living with GPP often do not receive a correct or timely diagnosis and may have their symptoms identified as other forms of psoriasis. A Global Consensus Delphi Panel of experts concluded a systematic literature review that classified GPP as phenotypically, genetically, immunologically, and histopathologically distinct from psoriasis vulgaris/plaque psoriasis. The growing list of regulatory approvals for SPEVIGO underlines that the Delphi panel’s vision of improved diagnosis and treatment for people with GPP is increasingly achievable.

Read also: Boehringer Ingelheim gets USFDA nod for high-concentration, citrate-free formulation of Cyltezo to treat multiple chronic inflammatory diseases

Powered by WPeMatico

NMC warns against person impersonating as Dr BN Gangadhar, NMC Chairman

New Delhi: Through a recent notice, the National Medical Commission (NMC) has warned the public against an individual impersonating the Chairman of NMC, Dr B N Gangadhar. The Apex Medical Regulator informed that the concerned individual is engaging with others claiming to be the NMC chairman using a specific mobile number i.e. 7050392639.

Issuing the notice, the Commission has clarified that the mobile number in question does not belong to Dr Gangadhar and advised the public not to engage with the person.

“It has come to our attention that an individual with the mobile number +917050392639 is impersonating as Dr. B.N. Gangadhar, Chairman of the National Medical Commission (NMC),” the Policy & Coordination Division of the Commission mentioned in the notice dated 17.05.2024.

Informing that “this mobile number does not belong to Dr. B.N. Gangadhar, Chairman, NMC,” the Commission further added, “The public is advised not to engage in any conversation with the person using the mobile number +917050392639, claiming to be Dr. B.N. Gangadhar. Any individual taking cognizance or acting on such conversations does so at their own risk.”

“This notice is issued to safeguard the public from any misinformation and to prevent any unauthorized activities carried out by the impersonator,” NMC clarified.

Also Read: NMC Warns Against Impersonator Claiming to be Chairman Dr BN Gangadhar

This is not the first time that the Commission has warned the public against impersonation of its officials. Time and again, the Commission warned the public against fake notices being circulated under its name.

Medical Dialogues had reported that earlier this year, NMC had issued a warning against an impersonator allegedly engaging with others using a specific mobile number i.e. +919062719187, and claiming to be the chairperson of the Commission, Dr BN Gangadhar. Back then also, the Commission had advised the public not to engage in any conversation with the person using the concerned mobile number.

Last year in December, NMC issued clarification regarding a letter bearing the signature of the Under Secretary of NMC PG Board and claiming that CPS degrees are recognised for the students undergoing training. Issuing a notice on December 14, 2023, the Apex Medical Commission said that the concerned notice was fake and warned the doctors against the fake letter.

To view the NMC notice, click on the link below:

https://medicaldialogues.in/pdf_upload/nmc-impersonation-238586.pdf

Also Read:Fact Check: NMC Letter Recognising CPS Courses for Doctors Undergoing Training is FAKE

Powered by WPeMatico

2 Gurugram doctors lose Rs 35 lakh in hospital loan fraud

Gurugram: In a fraud case reported from the city, two doctors cum owners of a private multi-speciality hospital fell prey to loan fraud and lost around Rs 35 lakh following which the police have registered a case in connection.  

According to the police, the doctors were promised that they would get a loan from foreign investors to expand their hospital however, they were scammed and lost their money. 

The victims have been identified as Dr Himanshu Gupta and Dr Vaibhav Bhola, owners of Nivaran Multi Speciality Hospital on the Old Delhi-Gurugram Road in Sector 23A and the suspects – Suresh Yadav, a resident of DLF 2 and Shavi Verma from Zirakpur in Punjab.

Also read- Mumbai Doctor Cheated Of Rs 9 Lakh In Fake Money Laundering Case

According to a TOI news report, the doctors were trying to arrange funds at low interest rates to expand their hospital. The incident dates back to December  2023 when the doctors were approached by Suresh who offered to facilitate a loan at nominal or no interest in the form of external commercial borrowings from foreign entities.

Yadav then introduced the doctors to Verma, whom they met at his office in Zirakpur. The suspects sought Rs 35 lakh from the doctors on the condition that they would return it and charge a 10% commission on the loan amount later.

In their complaint, the doctors alleged that they had consented to the conditions and handed over a sum of Rs 35 lakh in cash to Suresh. Allegedly, Suresh had assured the doctors that either he or Verma would return the amount if they were unable to secure a sanctioned loan.

The suspects informed them on February 26 that the loan was sanctioned by a firm in the UK and asked them to send their hospital documents and bank statement to it through email.

As per The Daily, Dr Bhola said, “As per his instructions, we sent documents related to our business expansion plan to the email ID given by Verma. We were suspicious since the name of the company he had mentioned was different from the company’s name in the email ID. But Shavi Verma assured us that the email provided belonged to a consultant firm handling all processes for the loan provider.”

Following this, on February 27, the doctors were given a ‘loan agreement’ to sign. After signing, they received an email confirming the transfer of a loan of around Rs 3 crore in euros from an international bank to their account.

“As soon as we received the mail, Verma started demanding his commission. But we did not pay since the amount was not credited into our bank account,” Dr Bhola said.

“The next day, we received a loan agreement copy which was signed and sent back to the foreign firm via email. We received another email soon in which a SWIFT code for 332204 Euros loan disbursal was shared and the suspects mounted pressure for commission,” Dr Bhola added.

A senior police officer told HT, “The doctors contacted their bank and provided the SWIFT code but were surprised to learn that it was non-existent. The suspects later sent a loan disbursal letter from another bank in Frankfurt. Doctors again approached the bank for verification which informed them that they had communicated with their Frankfurt counterparts who refused to make any such transaction.”

“On March 1, the suspects sent the doctors the statement of another foreign bank, which has branches here, too, showing loan disbursal in their account. The doctors approached one of the branches of the bank whose authorities confirmed that the statement and SWIFT code sent to them was fake,” he said, adding that the suspects later stopped responding to the doctors’ calls after threatening them. 

After finding all the emails to be fake, the doctors approached the police and filed a case under sections 420 (cheating and dishonestly inducing delivery of property), 465 (punishment for forgery), 467 (forgery of valuable security, will etc), 471 (using as genuine a forged document) and 20B (criminal conspiracy) of the Indian Penal Code (IPC).

The police are currently investigating the case to nab the suspects.

Also read- Doctor Falls Victim To Stock Market Investment Scam, Loses Rs 76 Lakh

Powered by WPeMatico

Zydus Lifesciences appoints Shelina Parikh as Additional Director, Independent Director

Ahmedabad: Zydus Lifesciences has approved the appointment of Shelina Parikh as an Additional Director as well as Independent Director of the Company for the first term
of 5 (five) consecutive years.

Shelina Parikh is the Joint Managing Director of TechNova Group, a privately held, family business group with interests in imaging solutions, chemicals and
industrial products.
Its main company, TechNova Imaging Systems, is the largest manufacturer of
offset and digital print solutions in India, and the fifth largest in the world.
TechNova’s business portfolio covers Specialty Chemicals, Offset Printing
Plates, Digital Print Media and Digital Print Equipment & Software. Globally
recognised as a pioneer, TechNova’s innovative products cater to a range of
industries such as Commercial & Newspaper Printing, Packaging, Publishing,
Signage, Photo, Textile and Medical Imaging.
As Joint MD, she is passionate about innovation, technology and mentoring
leaders. She is instrumental in strengthening TechNova’s strategic
operations, business transformation, market leadership position, digitisation
and new growth engines.
Her emphasis on the spiritual values of zero-ego, humility, trust,
transparency, kindness and life-time employment are combined with a focus
on high performance metrics, passion for excellence, leaner structures and
strong corporate governance. This unique ethos has established a vibrant,
innovative organisation that is recognised as a global leader in the Imaging
Industry.
She is a member of Young Presidents Organisation and a founding member
of Entrepreneurs Organisation in India.
She completed her B.A. from Brown University and MBA from Harvard
Business School. She remains engaged with Harvard Business School, as Vice
President of the HBS Global Alumni Board and member of the HBS South Asia
Advisory Board.

Headquartered in Ahmedabad, Zydus Lifesciences Limited is an innovative, global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group has a significant presence in cancer-related therapies and offers a wide range of solutions with cytotoxic, supportive & targeted drugs. 

Read also: Zydus Lifesciences completes enrolment for EPICS III Phase 2b/3 trial evaluating Saroglitazar Mg for Primary Biliary Cholangitis

Powered by WPeMatico

Unavailability of cotton swabs, doctors: Delhi HC seeks Govt response over hospitals denying treatment to minor

New Delhi: The Delhi High Court has taken cognizance of a distressing incident where a minor boy was denied treatment at two government-run hospitals due to the unavailability of cotton swabs and doctors. Terming the incident “shocking,” the court has directed the Delhi government to respond to the matter within 10 days.

Justice Subramonium Prasad issued notice to the Delhi government asking it to file a status report within 10 days.

The court has demanded a status report from the Delhi government, which will not only address the specific case but also shed light on the overall condition of government-run hospitals in the capital. The next hearing is scheduled for May 30.

Acording to a PTI report, The petition contended that the conduct of the two Delhi government-run hospitals– Dr Hedgewar Aarogya Sansthan and Chacha Nehru Bal Chikitsalaya– denying treatment to the petitioner, a school boy, for want of cotton and non-availability of doctor is “illegal, arbitrarily, malafide, unethical and violates the fundamental right to health”. 

Also Read:NHRC sends notice to Director AIIMS over denial of treatment to a road accident victim

The petitioner, represented by advocates Ashok Agarwal and Kumar Utkarsh, said it is a case of criminal negligence on the part of the hospitals.

The plea sought a direction to the Delhi government to reimburse medical expenses of Rs 12,000 incurred on his treatment and grant Rs 1 lakh as compensation to the child.

The incident occurred on April 1, when the boy, a third-grade student, suffered a fractured arm while playing at school. Despite being rushed to Dr. Hedgewar Aarogya Sansthan, he was refused treatment due to the unavailability of cotton swabs. Subsequently, at Chacha Nehru Bal Chikitsalaya, the family was informed that no doctors were present as it was past working hours.

The plea said that on the boy’s emergency card, the doctor on duty wrote “Cotton NA” and the boy was advised to buy the same.

It said the boy’s father, who works as a security guard, took him to Chacha Nehru Bal Chikitsalaya where they were told that “no doctor was available as it was already 5:30 p.m.” and doctors had “left the hospital at 3 p.m.”, news agency PTI reported.

Left with no other option, the petitioner was taken to a private clinic which then referred him to Chandra Laxmi Hospital where his left arm was plastered at midnight, the petition said.

The plea said the child’s mother works as a maid servant and she borrowed Rs 12,000 from her employer to pay the bills.

It claimed the Delhi government miserably failed to perform its constitutional obligation to provide to its residents “free and quality health care”.

The lawyers said they served a legal notice to the government against denial of medical treatment at the two state-run hospitals and asked it to reimburse the expenses along with a compensation of Rs 1 lakh but no response was received.

Powered by WPeMatico